Who founded Kopra Bio?

Kopra Bio was founded by Alexander Haddad in 2024.

Who are Kopra Bio's investors?

Kopra Bio's investors include Boutique Venture Partners, Chamaeleon, Lexi Ventures, Metaplanet, Mythos Ventures Management, Llc, Noxo Capital, Pioneer, Sparkwave Capital and 13 more.

Where is Kopra Bio headquartered?

Kopra Bio is headquartered in San Francisco, US.

Kopra Bio

YC S24

San Francisco, US · Founded 2024 · 2 employees · 21 known investors

Find your way into Kopra Bio

Paths you didn't know you had: your email and LinkedIn already hold routes to the Kopra Bio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Kopra Bio develops cancer immunotherapy technology that converts cancer cells into biofactories to produce their own destruction. The company operates in the biotech and cancer treatment space.

Also known as GlioTx

Biotech Healthtech Medical Devices Gene Therapy Synthetic Biology Therapeutics OncologyUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (S24)

Kopra Bio was founded in 2024 by Alexander Haddad.

Alexander Haddad FounderAlexander Haddad is a neurosurgery resident at UCSF who co-founded Kopra Bio, focusing on cell and gene therapy delivery to the central nervous system. He has authored over 70 peer-reviewed publications in neurosurgery.

Andrew BartynskiCEO

Investors · 21

Boutique Venture Partnerslisted by Boutique Venture PartnersPalo Alto

How we know: Y Combinator's founder network · Not right? Tell us

Chamaeleonlisted by ChamaeleonSilicon Valley · $1M – $5M

How we know: Chamaeleon's portfolio page · Not right? Tell us

Lexi Ventureslisted by Lexi VenturesSan Francisco

How we know: Lexi Ventures's portfolio page · Not right? Tell us

Metaplanetlisted by MetaplanetTallinn · $500K – $10M

How we know: Metaplanet's portfolio page · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Mythos Ventures Management, Llclisted by Mythos Ventures Management, LlcSeattle · $100K – $2M

How we know: Mythos Ventures Management, Llc's portfolio page · Y Combinator's founder network · Not right? Tell us

Noxo Capitallisted by Noxo Capital$51.5K

How we know: Noxo Capital's portfolio page · Not right? Tell us

Pioneerlisted by PioneerToronto, Ontario

How we know: Y Combinator's founder network · pioneerfund.vc · open dataset · 5k.vc investor directory · Not right? Tell us

Sparkwave Capitallisted by Sparkwave Capital

How we know: Y Combinator's founder network · Not right? Tell us

Transpose Platform Managementlisted by Transpose Platform ManagementSan Francisco

How we know: Transpose Platform Management's portfolio page · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Agrolimen Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Andreessen HorowitzreportedMenlo Park · $500K – $50M

How we know: Y Combinator's founder network · Not right? Tell us

Capitalize VCreportedChicago · $100K – $200K

How we know: Y Combinator's founder network · Not right? Tell us

Grey Street PartnersreportedMelbourne · $50K

How we know: Y Combinator's founder network · Not right? Tell us

Jolt CapitalreportedParis · $11M – $55M

How we know: Y Combinator's founder network · Not right? Tell us

MCMA Ventures, LLCreportedDenver

How we know: Y Combinator's founder network · Not right? Tell us

Metsu Capitalreported

How we know: Y Combinator's founder network · Not right? Tell us

North South VenturesreportedToronto

How we know: Y Combinator's founder network · Not right? Tell us

OurCrowdreportedJerusalem

How we know: Y Combinator's founder network · Not right? Tell us

Red Rooster VenturesreportedSan Mateo

How we know: Y Combinator's founder network · Not right? Tell us

Singularity Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 8

Modulari-TModulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.

CarterraCarterra designs and manufactures flexible microfluidic manufacturing systems for the life sciences and biotech research markets. The company serves research laboratories and biotech companies requiring high-throughput analysis and manufacturing capabilities.

ParcelBioParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies. The platform targets autoimmune disease, oncology, and therapeutic protein replacement applications.

Bicara TherapeuticsBicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibody therapies that combine tumor-targeting with immune-modulating payloads to treat solid tumors. The company's lead program, ficerafusp alfa, fuses an EGFR-directed antibody with a TGF-β ligand trap to simultaneously inhibit tumor cell growth and suppress immunosuppressive signaling in the tumor microenvironment, with initial development focused on head and neck squamous cell carcinoma.

Granza BioGranza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.

bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.

SynsoryBioSynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.

Eugit TherapeuticsTissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.

Companies working in the same space as Kopra Bio.

Legal entities · 1

corporate structure

Kopra Bio, Inc.

In the news

9 startups that stood out on YC Demo Day 2techcrunch.com · Sep 2024

🔬🧠🧬 Kopra Bio - Making cancer cures using viral immunotherapyycombinator.com · Aug 2024

Frequently asked questions

What does Kopra Bio do?: Kopra Bio develops cancer immunotherapy technology that converts cancer cells into biofactories to produce their own destruction. The company operates in the biotech and cancer treatment space.
Who founded Kopra Bio?: Kopra Bio was founded by Alexander Haddad in 2024.
Who are Kopra Bio's investors?: Kopra Bio's investors include Boutique Venture Partners, Chamaeleon, Lexi Ventures, Metaplanet, Mythos Ventures Management, Llc, Noxo Capital, Pioneer, Sparkwave Capital and 13 more.
Where is Kopra Bio headquartered?: Kopra Bio is headquartered in San Francisco, US.